Scripps Diabetes Researcher Presents Weekly Insulin Study Results
Scripps Whittier Institute for Diabetes plays lead role in testing experimental therapy
Scripps Whittier Institute for Diabetes plays lead role in testing experimental therapy
Scripps Whittier Institute for Diabetes’ leading role in the global effort to develop long-acting insulin was on full display recently when the institute’s corporate vice president, Athena Philis-Tsimikas, MD, presented encouraging clinical trial results at a major medical conference in Stockholm.
Dr. Philis-Tsimikas was a lead investigator in the study that compared an experimental weekly insulin shot to the more typical one-a-day insulin shot in patients with type 2 diabetes.
Watch the 10News report: Scripps Health Study Could Drasticaally Cut Insulin Shots From Once a Day to Once a Week
Read the San Diego Union-Tribune article: Once-Per-Week Insulin Shots? New Research by Scripps Doctor Showing Promise
Read the BioSpace article: Novo’s Once-Weekly Insulin Treatment Part of a Transforming T2D Space
Media Contact
- Keith Darce
- 858-678-7121
- darce.keith@scrippshealth.org
- Follow me: @KeithDarce